Quantitative evaluation of the impact of relaxing eligibility criteria on the risk–benefit profile of drugs for lung cancer based on real‐world data
Abstract Introduction Restrictive eligibility criteria in cancer drug trials result in low enrollment rates and limited population diversity. Relaxed eligibility criteria (REC) based on solid evidence is becoming necessary for stakeholders worldwide. However, the absence of high‐quality, favorable e...
Збережено в:
| Автори: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2024-05-01
|
| Серія: | Thoracic Cancer |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1111/1759-7714.15269 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|